velusetrag

Small moleculeexperimental

Velusetrag (INN, USAN; previously known as TD-5108) is an experimental drug candidate for the treatment of gastric neuromuscular disorders including gastroparesis, and lower gastrointestinal motility disorders including chronic idiopathic constipation and irritable bowel syndrome. It is a potent, selective, high efficacy 5-HT4 receptor serotonin agonist being developed by Theravance Biopharma and Alfa Wassermann. Velusetrag demonstrates less selectivity for other serotonin receptors, such as 5-HT2 and 5-HT3, to earlier generation 5-HT agonists like cisapride and tegaserod. — Wikipedia

Clinical trial activity

4 trials · 2 clinical orgs · 0 marketing orgs

Phase 1
1
Phase 2
3
Phase 3
0
Phase 4
0

Earliest trial started Oct 1, 2006 (NCT00391820)

Timeline

2000s

  1. Jan 1, 2006

    Earliest Phase 2 Sponsor(trial)

2010s

  1. Jan 1, 2011

    Earliest Phase 1 Sponsor(trial)

Indications

Mechanism of action

Chemistry & pharmacology

Loading structure…

SMILES

CC(C)n1c(=O)c(C(=O)N[C@H]2C[C@H]3CC[C@@H](C2)N3C[C@@H](O)CN(C)S(C)(=O)=O)cc2ccccc21
Mol. weight
504.65 g/mol
Lipinski Ro5
1 violation(s)
Rule of 3
No
Chirality
Single Stereoisomer
Inorganic
No
Polymer
No

Oral

No

Parenteral

No

Topical

No

Sources

Also known as

  • 1-isopropyl-2-oxo-1,2-dihydroquinoline-3-carboxylic acid ((1s,3r,5r)-8-((r)-2-hydroxy-3-(methanesulfonyl-methyl-amino)propyl)-8-aza-bicyclo(3.2.1)oct-3-yl)amide
  • td5108
  • td-5108
  • td-5108
  • td-5108
  • td-5108
  • velusetrag
  • velusetrag
  • velusetrag
  • velusetrag
  • velusetrag

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT02267525Phase 2Dec 1, 2014Alfa Wassermann, Theravance
NCT01718938Phase 2Dec 1, 2012Alfa Wassermann, Theravance
NCT01467726Phase 1Nov 1, 2011Theravance
NCT00391820Phase 2Oct 1, 2006Theravance
Showing 4 of 4 trials
Page 1 / 1

Organizations

Research & Development (2)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
TheravanceFor profit4422006
Alfa WassermannFor profit2012012
2 organizations
Page 1 / 1